Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf

Kiniksa Pharmaceuticals (KNSA) on Friday filed a registration statement for the potential offering of up to $400 million worth of securities from time to time. The filing covers the potential sale of

MT NewswiresJul 1 17:22

Express News | Kiniksa Pharmaceuticals Ltd Files for Mixed Shelf of up to $400 Mln - SEC Filing

BreakingsJun 29 05:30

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

Health care stocks were mixed pre-bell Wednesday, with the iShares Biotechnology ETF (IBB) down 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.5% recently. Savara (SVRA) rose past 17% aft

MT NewswiresJun 26 21:18

Express News | Kiniksa Pharmaceuticals - Samsung to Perform Tech. Transfer, Process Performance Qualification, Manufacturing & Supply Services for Supply of Arcalyst

BreakingsJun 26 04:35

Express News | Kiniksa Pharmaceuticals Ltd - Unit Entered Master Services Agreement and Product Specific Agreement With Samsung Biologics Co., Ltd.

BreakingsJun 26 04:33

Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA

Seeking AlphaJun 26 02:07